Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5829_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
11 Мб
Скачать
☆
196 F. Ciompi et al.
Tabl e 2 Performance as MEAN(STD)ofIvtDand pSFFS methods when classifying in-vitro data. The
overall accuracy (A), the sensitivity (S), specificity (K)
and precision (P)are computed when discriminating fibrotic (fib), lipidic (lip)andcalcified (cal) plaque
100
98
96
94
performance %
92
IvtD pSFFS
A 89.93 (0.29) 91.59 (0.47) S
fib
S
lip
S
cal
K
fib
K
lip
K
cal
P
fib
P
lip
P
cal
90.46 (0.60) 92.58 (0.95)
80.49 (0.80) 85.21 (0.59)
92.20 (0.46) 92.29 (0.75)
92.16 (0.41) 93.85 (0.34)
95.50 (0.17) 96.47 (0.37)
96.15 (0.48) 96.21 (0.38)
93.34 (0.33) 94.72 (0.30)
69.48 (0.86) 74.78 (2.09)
92.48 (0.86) 93.23 (0.62)
J Accuracy Sfibrotic Slipidic Scalcified
90
88
1 2 3 4 5 6 7 8 9 10 11 12
Iteration [k]
Fig. 11 Example of thepSFFS algorithm performance up to 12th iteration. This case is specific for a generic pth necro case. J is the value achieved at each iteration during the data selection process, while the overall accuracy and sensitivity (S) for each tissue type are computed by characterizing
p
data at each iteration
the X
val
4.5 Test In Vitro
Tabl e 2 shows the classification parameters for the pSFFS methods when charac­terizing in vitro data, compared with the initial plaque characterization performance using exclusively in vitro data (IvtD) as training set. In pSFFS, the classifier has been trained by using the enhanced data set obtained by applying the data fusion method. Note that the algorithm provides a mean improvement in performance parameters
Coronary Atherosclerotic Plaque Characterization By Intravascular Ultrasound 197
Fig. 12 Plaque characterization on IVUS data. First column: original IVUS images; second column: histologically validated ground-truth plaque segmentation; third column: classification result in the regions defined by histology. Yellow, green and blue (corresponding to light, medium and dark grey) colors indicate lipidic, fibrotic and calcified tissue, respectively
of 1.9% with respect to the IvtD case. Figure 11 shows an example of the changes of performance parameters during thepSFFS algorithm for a generic patient. Figure12 shows some examples of plaque characterization in IVUS images where tissues are labeled using the enhanced classifier.
4.6 Test In Vivo
The results on Table 2 prove that the enhanced classifier outperforms a classifier trained and validated only on in vitro cases. Note that the last approach has been
198 F. Ciompi et al.
Tabl e 3 Performance as MEAN (STD) of Ivt vs pSFFS methods in classifying in-vivo data. The overall accuracy (A),thesensitivity
(S), specificity (K) and precision (P) are computed when discriminating fibrotic (fib), lipidic (lip) and calcified (cal) plaque
A 74.05 (1.34) 87.09 (0.33) S
fib
S
lip
S
cal
K
fib
K
lip
K
cal
P
fib
P
lip
P
cal
IvtD pSFFS
88.49 (3.36) 90.66 (0.43)
27.87 (3.50) 58.46 (1.61)
99.62 (0.11) 99.37 (0.22)
67.54 (1.53) 85.86 (0.55)
97.53 (1.49) 98.56 (0.09)
96.67 (0.26) 96.32 (0.24)
55.90 (1.27) 73.85 (0.72)
83.93 (7.95) 92.59 (0.33)
94.74 (0.38) 95.82 (0.26)
followed by almost all the plaque characterization methods presented in the last ten years, on the hypothesis that the differences between in vitro and in vivo data are negligible.
In the data fusion approach, the training data set is designed by fusing in vivo and in vitro IVUS data. It is then reasonable to assume that the enhanced classifier could exhibit better performance in discriminating in vivo data with respect to a classifier trained only with in vitro data. Note that this assumption does not imply any hypothesis on the similarity between in vivo and in vitro data; it is in fact naturally deduced since the enhanced data set includes examples of in vivo data, thus providing to the classifier a knowledge about the spatial distribution of in vivo points. In order to prove the last hypothesis, the classification results of both the IvtD and the pSFFS classifiers when discriminating plaques in in vivo cases are compared: Table 3 shows the obtained classification performance in both cases.
Given the impossibility of obtaining the absolute knowledge on in vivo tissue composition by histological analysis, it is clear that the obtained results cannot be considered as a reliable, though qualitative results. Notwithstanding that, the increment of about 13% in overall accuracy when the pSFFS classifier is used indicates the benefits achieved in using an enhanced data set instead of a pure in vitro training set.
References
1. Shah PK (2003) Mechanism of plaque vulnerability and rupture. JACC 41(1):15–22
2. Burke AP, Farb A, Malcom GT, Liang Y, Smialek J, Virmani R (1997) Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. New Engl J Med 336:1276–1281
3. Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ (2005) Atherothrombosis and high-risk plaque. JACC 46(6):937–54
4. Ehara S, Kobayashi Y, Yoshiyama M, Shimada K, Shimada Y, Fukuda D, Nakamura Y, Yamashita H, Yamagishi H, Takeuchi K, Naruko T, Haze K, Becker AE, Yoshikawa J, Ueda M (2004) Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: An intravascular ultrasound study. Circulation 110:3424–3429
Coronary Atherosclerotic Plaque Characterization By Intravascular Ultrasound 199
5. Willerson JT, Wellens HJJ, Cohn JN, Holmes DR (2007) Atherosclerotic vulnerable plaques: Pathophysiology, detection, and treatment. Cardiovasc Med 10:621–639
6. Davies MJ, Thomas AC (1985) Plaque fissuring – the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 53(4):363–73
7. Schaberle W (2004) Ultrasonography in vascular diagnosis. Springer, Berlin
8. Gorge G, Ge J, Baumgart D, von Birgelen C, Erbel R (1998) In vivo tomographic assessment of the heart and blood vessels with intravascular ultrasound. Basic Res Cardiol 93(4):219–240
9. Nissen SE, Yock P (2001) Intravascular ultrasound: Novel pathophysiological insights and current clinical applications. Circulation 103:604–616
10. Ellis SG, Holmes DR Jr (eds) (2006) Strategic approaches in coronary intervention, 3rd edn. Lippincott Williams & Wilkins, PA
11. Siegel RJ (ed) (1998) Intravascular ultrasound imaging in coronary artery disease Informa Healthcare; 1st edition (January 15, 1998)
12. Zhang X, McKay CR, Sonka M (1998) Tissue characterization in intravascular ultrasound images. TMI 17(6):889–899
13. Caballero KL, Barajas J, Pujol O, Salvatella N, Radeva P (2006) In-vivo ivus tissue classifica­tion: A comparison between rf signal analysis and reconstructed image. Progr Pattern Recognit Image Anal Appl 4225/2006:137–146
14. Caballero KL, Barajas J, Pujol O, Rodriguez O, Radeva P (2007) Using reconstructed ivus images for coronary plaque classification. EMBS, pp. 2167–2170
15. Moore M et al (1998) Characterisation of coronary atherosclerotic morphology by spectral analysis of radiofrequency signal: In vitro intravascular ultrasound study with histological and radiological validation. Heart 79(5):459–467
16. Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG (2002) Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 106:2200–2206
17. Nair A, Kuban BD, Obuchowski N, Vince GD (2001) Assessing spectral algorithms to predict atherosclerotic plaque composition with normalized and raw intravascular ultrasound data. UMB 27(10):1319–1331
18. Katouzian A, Sathyanarayana S, Baseri B, Konofagou EE, Carlier SG (2008) Challenges in atherosclerotic plaque characterization with intravascular ultrasound (ivus): From data collection to classification. TITB 12(3):315–327
19. Bedekar D (2003) Atherosclerotic plaque characterization by acoustic impedance analysis of intravascular ultrasound data. IEEE Ultrason Symp, pp. 1524–1527
20. Sathyaranayana S, Carlier S, Wenguang L, Thomas L (2009) Characterization of atheroscle­rotic plaque by spectral similarity of radiofrequency intravascular ultrasound signals. EuroInt­ervention 5:133–139
21. Kawasaki M, Takatsu H, Noda T, Ito Y, Kunishima A, Arai M, Nishigaki K, Takemura G, Morita N, Minatoguchi S, Fujiwara H (2001) Noninvasive quantitative tissue characterization and two-dimensional color-coded map of human atherosclerotic lesions using ultrasound integrated backscatter. JACC 38(2):486–492
22. Kawasaki M, Takatsu H, Noda T, Sano K, Ito Y, Hayakawa K, Tsuchiya K, Arai M, Nishigaki K, Takemura G, Minatoguchi S, Fujiwara T, Fujiwara H (2002) Invivo quan­titative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings. Circulation 105:2487–2492
23. Kawasaki M, Sano K, Okubo M, Yokoyama H, Ito Y, Murata I, Tsuchiya K, Minatoguchi S, Zhou X, Fujita H, Fujiwara H (2005) Volumetric quantitative analysis of tissue character­istics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasounds. JACC 45(12):1946–1953
24. Murashige A, Hiro T, Fujii T, Imoto K, Murata T, Fukumoto Y, Matsuzaki M (2005) Detection of lipid-laden atherosclerotic plaque by wavelet analysis of radiofrequency in­travascular ultrasound signals: In vitro validation and preliminary in vivo application. JACC 45(12):1954–1960
200 F. Ciompi et al.
25. Gonzalez RC, Woods RE (2001) Digital image processing, 2nd edn. Prentice Hall, NJ
26. Mehta SK, McCrary JR, Frutkin AD, Dolla WJS, Marso SP (2007) Intravascular ultrasound radiofrequency analysis of coronary atherosclerosis: An emerging technology fot the assess­ment of vulnerable plaque. Eur Heart J 28:1283–1288
27. Tobocman W, Santosh K, Carter JR, Haacke EM (1994) Tissue characterization of arteries with 4MHZ ultrasound. Ultrasonics 33:331–339
28. Milunski MR, Mohr GA, Perez JE, Vered Z, Wear KA, Gessler CJ, Sobel BE, Miller JG, Wickline SA (1989) Ultrasonic tissue characterization with integrated backscatter. acute myocardial ischemia, reperfusion, and stunned myocardium in patients. Circulation 80:491–503
29. Ciompi F, Pujol O, Gatta C, Rodriguez-Leor O, Mauri-Ferre J, Radeva P (2010) Fusing in-vitro and in-vivo intravascular ultrasound data for plaque characterization. IJCI 26:763–779
30. Carlier SG, Tanaka K, Katouzian A (2007) Atherosclerotic plaque characterization from radio frequency ultrasound signal processing. US Cardiovascular Disease, pp 54–56
31. Katouzian A, Baseri B, Konofagou EE, Laine AF (2008) Automatic detection of blood versus non-blood regions on intravascular ultrasound (ivus) images using wavelet packet signatures. Proc SPIE 6920, pp 1–8
32. Addison PS (2002) The illustrated wavelet transform handbook. Publishing, Institute of Physics
33. Escalera S, Pujol O, Mauri J, Radeva P (2008) Ivus tissue characterization with sub-class error­correcting output codes. J Signal Process Syst 55:35–47
34. Ciompi F (2008) Ecoc-based plaque classification using in-vivo and ex-vivo intravascular ultrasound data. Master thesis
35. Dietterich TG, Bakiri G (1995) Solving multiclass learning problems via error-correcting output codes. JAIR 2:263–286
36. Rifkin R, Klautau A (2004) In defense of one-vs-all classification. JMLR 5:101–141
37. Pudil P, Ferri FJ, Novovicova J, Kittler J (1994) Floating search methods for feature selection with nonmonotonic criterion functions. ICPR 2:279–283
38. Allwein EL, Schapire RE, Singer Y (2000) Reducing multiclassto binary: A unifying approach for margin classifiers. Proceedings of the Seventeenth International Conference on Machine Learning, pp 9–16
39. Schapire R (2002) The boosting approach to machine learning: an overview. MSRI Workshop on Nonlinear Estimation and Classification, pp 1–23
Francesco Ciompi F. Ciompi received the MS degree in Electronic Engineering from the Universit`adiPisain 2006 and the MS in Computer Vision and Artificial In­telligence from the Universitat Aut´onoma de Barcelona in 2008. He is currently a PhD student at the dept. of Applied Mathematics and Analysis at the Universitat de Barcelona. His research interests include the use of machine learning techniques for the classification and segmentation of Intravascular Ultrasound data.
Coronary Atherosclerotic Plaque Characterization By Intravascular Ultrasound 201
Oriol Pujol Oriol Pujol is associate professor at dept. of Applied Mathematics and Analysis of University of Barcelona since 2008, and senior researcher at Computer Vision Center. He has been since 2004 an active member in the organization of several activities related to image analysis, computer vision, machine learning and artificial intelligence. In applied research he is working in medical image analysis, object recognition, wearable computing and augmented reality.
Josepa Mauri Ferr´e Josepa Mauri received the title of MD in 1982 at Universitat Aut`onoma de Barcelona. In 1992 she received the Laurea summa Cum Laude in Medicine at the Universitat de Barcelona. Since 2000, she is the Director of Cardiac Catherization Laboratory in the Hospital Universitari “Germans Trias I Pujol de Badalona”. From 2002 to 2005 she was the President of the Diagnostic Intracoronary Technics/IVUS Working Group of the Spanish Society of Cardiology. From 2006
to 2009 she was the President of the Spanish Working Group in Cardiac Interventions of the Spanish Society of Cardiology. Her clinical research areas have been in coronary angioplasty and Dilated Cardiomyopathy, dilated Cardiomiopathy, coronary angioplasty, stents, endothelial disfunction and IVUS studies. She is currently involved in international educational projects in interventional cardiology.
Petia Radeva Petia Radeva (PhD 1998, Universitat
Aut`onoma de Barcelona, Spain) is a senior researcher
at UB. She has more than 150 publications in interna-
tional journals and proceedings. Her present research
interests are development of learning-based approaches
(in particular statistical methods) for computer vision
and medical imaging. She has led one EU project and
several Spanish projects. She has 12 patents in the field
of medical imaging. Currently, she is heading projects in the field of cardiac imaging and wireless endoscopy in collaboration with Spanish hospitals and international medical imaging companies.
Three-Dimensional Ultrasound Plaque Characterization
Jos´e Seabra, Jasjit S. Suri, and Jo˜ao Miguel Sanches
Abstract The chapter proposes a framework for extending the analysis of the
atherosclerotic disease to a three-dimensional perspective. Different data acquisition systems, either based on a robotic arm setup or free-hand are proposed, in order to collect image sequences that completely describe the plaque anatomy. A 3D reconstruction method is proposed, comprising a Rayleigh based de-speckling approach and interpolation. As a consequence, 3D maps accounting for plaque echogenicity and texture, according to appropriate local Rayleigh estimators are obtained. Furthermore, the applicationof a segmentation approach which makes use of the Graph-cuts method, provides an efficient way to segment and locally identify unstable regions throughout the plaque. This information, complemented with a more accurate inspection of plaque morphology, may have an important clinical impact in disease diagnosis.
1 Introduction
Atherosclerosis is a disease which generally affects large and medium-sized ar­teries and its most important feature is plaque formation due to progressive sub-endothelial accumulation of lipid, protein, and cholesterol esters in the blood vessel wall.
Several studies recognize that the degree of stenosis, obstruction to the blood
flow, is an important physiological landmark of stroke but that other parame-
J. Seabra () • J.M. Sanches Institute for Systems and Robotics, Department of Bioengineering from the Instituto Superior T´ecnico/Technical University of Lisbon, Portugal e-mail: mail2jseabra@gmail.com; jmrs@ist.utl.pt
J.S. Suri Biomedical Technologies, Inc., Denver, CO, USA
Idaho State University (Affiliated), Pocatello, ID, USA e-mail: jsuri@comcast.net
J.M. Sanches et al. (eds.), Ultrasound Imaging: Advances and Applications, DOI 10.1007/978-1-4614-1180-2
9, © Springer Science+Business Media, LLC 2012
203
204 J. Seabra et al.
ters, such as plaque echo-morphology and texture should also be considered for designing a plaque risk profile. Additionally, it has been observed that vulnerable plaques are usually associated with fibrous cap thinning and infiltration of inflam­matory cells consequently leading to rupture. Other studies reported a positive correlation betweenthe presence offatty contents and hemorrhage with neurological symptoms, thus suggesting that inflammatory activity potentially determines plaque instability. In Pedro et al. [1, 2], the location and extension of these regions are identified as sensitive and relevant markers of stroke risk.
Numerous research groups conducted studies aiming at characterizing and identifying the main features of the symptomatic lesion [1,3–8]. Among these, the gray-scale median and P
can be used to characterize the plaque from an echogenic
40
viewpoint. However, the interpretation of these parameters values will fail to reveal possible unstable foci within the plaque, specially when plaques are heterogeneous or present significant hypoechogenic areas.
The risk assessment of plaque rupture through conventional 2D techniques is limited to a subjective selection of a representative image of plaque structure and it is hardly reproducible. An accurate diagnostic procedure based on 3D is known to be valuable but has not yet been adopted in clinical practice, mainly because such technology is not usually available in most medical facilities. Recently, less operator-dependent methods based on 3D US have been proposed from better assessment of plaque vulnerability [9, 10]. These studies aim at quantifying the plaque volume, degree of stenosis [11], and the extension of surface ulceration [12].
The focus of this chapter is to assess the atherosclerotic disease on a 3D perspective providing better visualization of the lesion and characterization of potential risk. The carotid disease study in 3D is rooted on the reconstruction of 3D maps starting with 2D information extracted from noisy BUS images. To achieve the proposed objectives, different 3D image acquisition methods are explored and powerful methods for identifying vulnerable foci within the plaque volume are used.
2 Development of DAQ Systems for 3D Ultrasound
Medical US has benefited from major advances in technology and is considered an indispensable imaging modality due to its flexibility and non-invasive character.
Currently, there are accurate methods to assess the disease severity based on CT [13]orMRI[14]. However their application is expensive, time consuming, and requires equipment which is not yet available and accessible in most clinical facilities. On the other hand, 2D ultrasound is widely available and provides real time data acquisition and visualization, so it has been so far the preferred technique in the diagnosis and monitoring of the disease.
Although all anatomy is 3D in form, the vast majority of US imaging is 2D. Most of the times, this technique provides sufficient information for diagnosis but there are clearly identifiable limitations, such as, non-ability to perform quantitative
Three-Dimensional Ultrasound Plaque Characterization 205
volume measurements or to obtain optimal 2D scan views of the anatomical ROI (Region of Interest). Consequently, 3D US is a logical solution to allow better, more completeand objective diagnostic results. In this imagingmodality, the 2D US images are combined by a computer to form an objective 3D image of the anatomy and pathology. This data can be manipulated and measured in 3D both in real time or later off-line. Moreover, unlike CT and MR imaging, in which 2D images are usually acquired at a slow rate as a stack of parallel slices, in a fixed orientation, US provides images at a high rate (15–60 s
−1
) and in arbitrary orientations.
Most 3D US systems make use of a conventional transducer to obtain a sequence of images by sweeping the probe along the anatomical ROI, and differ only in acquisition and position sensing [9]. In this way, images can be acquired mechanically, free-handed with or without an optical or electromagnetic spatial locator and using 2D arrays. Some of these systems were validated in various clinical applications, such as obstetrics, cardiology, and vascular imaging in order to increase the diagnosis confidence [15].
2.1 Robotic Arm Prototype
Depending on the organ or tissue to be scanned, it is necessary to apply different scanning strategies or protocols which comprise linear, rotatory, and free-hand scanning, just to name the most common ones. Most imaging systems are not optimally adapted for such a wide range of applications. Hence, a 3D US prototype robotic system which can control, standardize, and accurately perform the acquisi­tion process is presented. This system may assist the operator in defining suitable scanning paths for each patient according to the ROI to be scanned. Different acquisition properties can be assigned in each examination, such as the duration and rate of image acquisition. Moreover, each image is assigned with its spatial information allowing to further perform follow-up studies or to reconstruct and segment the tissues or organs scanned with higher degree of confidence.
Robotic systems can be regarded as an important diagnosis tool because they can simultaneously control and standardize the image acquisition process. Thus, they can be very suitable for quantifying and accurately monitor the development of cardiovascular diseases, namely, the progression of atheromatous plaques by scanning the carotid or coronary arteries [16]. In addition, the ability to remotely position the US probe with the robotic arm could also be used in telemedicine [17].
Given this, a prototype medical robot is described which can easily be integrated with common ultrasound scanning equipment and provides clinicians with their regular scanning operations. The prototype robotic arm is schematically shown in Fig. 1a and comprises four main components. The first unit is the robotic arm (Scorbot-ER VII, Intelitek, USA) with six degrees of freedom which is operated from the robot controller. The second element is an US portable scanner (Echo Blaster 128, Telemed, LT), equipped with alinear array probe. This probe isattached to the tip of the robotic arm, together with an electromagnetic position sensing
206 J. Seabra et al.
Fig. 1 Robotic Arm Prototype. (a) Block diagram of the system components. (b) Experimental setup. The robotic arm carries the probe and the position sensing receptor from the US scanner and the spatial locator, respectively. The workstation personal computer controls the movements of the robotic arm with the aid of a joystick. Images are tagged with their spatial location and showed on the screen. (c) Acquisition modes: linear (a), fan-like (b), and rotatory (c) scans
device (Fastrak, Polhemus, VT). The last component of the system is the computer workstation, which holds a joystick and the interface to control the medical robot and the US scanner.
A user-friendly graphical interface provides access and setting of the robotic arm controls and movements as well as visualization and tuning of acquisition results. The robotic arm is manipulated using a joystick which allows to move the US probe towardthe ROI to be scanned. Moreover,the system features a learningmode which enables to store in memory a suitable scan path, and a replay mode to reproduce the manually taught path. This attribute of the robotic system is suitable to guarantee reproducible and personalized results since a scan path can be assigned for each patient with controlled speed and accurate position information provided by the spatial locator.